By Katherine Hamilton
Electromed shares rose after the company said fiscal fourth-quarter sales and income rose.
The stock advanced 10% to $22.80 during after-hours trading Tuesday. At close, it was down 30% this year.
The health company, which specializes in technology designed to clear airways, said Tuesday its revenue increased 17% to $17.4 million in the three months ended on June 30. Its profit was $2.2 million, or 25 cents a share, compared with $1.8 million, or 20 cents a share, the year before.
Sales in Electromed's direct homecare business rose 15% primarily due to incremental referrals and approvals driven by an increase in direct sales representatives and higher revenue per approval.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
August 26, 2025 17:44 ET (21:44 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.